This COVID-19 roundup includes research on an alternative therapy to nirmatrelvir-ritonavir, a vaccine regimen that protects pregnant women and infants against certain variants, pegylated interferon lambda...
Researchers compared pre-exposure prophylaxis (PrEP) use with birth outcomes using objective levels of tenofovir-diphosphate (TFV-DP) in dried blood spots (DBS) of women during the second or third trimester...
In a recent clinical trial, researchers determined that mothers who took vitamin D supplements during pregnancy reduced the risk of atopic eczema in the baby’s first year.
Researchers conducted an observational study that examined the likelihood of newborns and infants having measles antibodies passed down from their mothers.
This COVID-19 roundup includes coverage on a revised version of the FDA’s emergency use authorization of tixagevimab/cilgavimab, a new study that compared the efficacy of vaccines and boosters in mortality...
According to a study, pregnant women without a previous diagnosis of hypertension developed postpartum hypertension—some more than 6 weeks after delivery.
In the largest study to date, researchers examined a possible link between anesthesia in pregnant women and neurodevelopmental outcomes in their children.
Despite most pertussis cases occurring in infants aged 2 months or younger, this patient population is too young to receive the childhood pertussis vaccine series. The approval of the pertussis vaccine...
The researchers examined a link between excessive weight gain during pregnancy and gestational diabetes in women and later diagnoses of ADHD in their children.
